Rana Ezzeddini

1.4k total citations
9 papers, 120 citations indexed

About

Rana Ezzeddini is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Rana Ezzeddini has authored 9 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Rana Ezzeddini's work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers) and T-cell and B-cell Immunology (2 papers). Rana Ezzeddini is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers) and T-cell and B-cell Immunology (2 papers). Rana Ezzeddini collaborates with scholars based in Iran, Sweden and United Kingdom. Rana Ezzeddini's co-authors include Mohammad Taghikhani, Amir Salek Farrokhi, Mohammad Javad Rasaee, Nasser Samadi, Mohammad Hossein Somi, Mohammad Hossein Somi, Ali Esfahani, Tohid Gharibi, Bahman Yousefi and Ghasem Ghalamfarsa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Cytokine.

In The Last Decade

Rana Ezzeddini

8 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rana Ezzeddini Iran 6 57 45 34 18 17 9 120
Bohan Dong China 8 72 1.3× 27 0.6× 39 1.1× 25 1.4× 10 0.6× 12 128
Marianna Romžová Czechia 7 59 1.0× 26 0.6× 53 1.6× 16 0.9× 17 1.0× 14 148
Carolina Marasco Italy 6 95 1.7× 26 0.6× 49 1.4× 33 1.8× 17 1.0× 10 168
Stephen Harper United Kingdom 7 100 1.8× 19 0.4× 31 0.9× 46 2.6× 23 1.4× 12 163
Joseph F. Boland United States 5 76 1.3× 27 0.6× 13 0.4× 17 0.9× 15 0.9× 8 120
Leticia Soriano‐Baguet Denmark 4 63 1.1× 30 0.7× 67 2.0× 36 2.0× 8 0.5× 4 133
Anne Song United States 4 60 1.1× 18 0.4× 49 1.4× 30 1.7× 6 0.4× 4 130
Yifan Sun China 6 101 1.8× 48 1.1× 59 1.7× 42 2.3× 6 0.4× 8 173
Jiaoyu Ai China 5 73 1.3× 42 0.9× 28 0.8× 37 2.1× 8 0.5× 10 137
George Sandusky United States 4 111 1.9× 23 0.5× 19 0.6× 42 2.3× 10 0.6× 6 165

Countries citing papers authored by Rana Ezzeddini

Since Specialization
Citations

This map shows the geographic impact of Rana Ezzeddini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rana Ezzeddini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rana Ezzeddini more than expected).

Fields of papers citing papers by Rana Ezzeddini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rana Ezzeddini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rana Ezzeddini. The network helps show where Rana Ezzeddini may publish in the future.

Co-authorship network of co-authors of Rana Ezzeddini

This figure shows the co-authorship network connecting the top 25 collaborators of Rana Ezzeddini. A scholar is included among the top collaborators of Rana Ezzeddini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rana Ezzeddini. Rana Ezzeddini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ezzeddini, Rana, et al.. (2024). Enhanced anti-tumor efficacy of S3I-201 in breast cancer mouse model through Wharton jelly- exosome. Cancer Cell International. 24(1). 318–318. 5 indexed citations
2.
Ezzeddini, Rana, et al.. (2023). Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti‐breast cancer immunity: An in vitro study. Scandinavian Journal of Immunology. 98(3). e13300–e13300. 1 indexed citations
3.
Ezzeddini, Rana, Mohammad Taghikhani, Amir Salek Farrokhi, et al.. (2021). Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance. Journal of Physiology and Biochemistry. 77(2). 249–260. 24 indexed citations
4.
Ezzeddini, Rana, et al.. (2020). Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients. Cytokine. 138. 155351–155351. 9 indexed citations
5.
Ghorban, Khodayar, et al.. (2019). PTPN22 1858 C/T polymorphism is associated with alteration of cytokine profiles as a potential pathogenic mechanism in rheumatoid arthritis. Immunology Letters. 216. 106–113. 14 indexed citations
6.
Ezzeddini, Rana, Mohammad Taghikhani, Mohammad Hossein Somi, Nasser Samadi, & Mohammad Javad Rasaee. (2019). Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. Life Sciences. 224. 169–176. 30 indexed citations
7.
Hashemi, Vida, Amir Salek Farrokhi, Asghar Tanomand, et al.. (2018). Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunology Letters. 204. 16–22. 26 indexed citations
8.
Mehdizadeh, Amir, et al.. (2018). The study of serum and tissue cholesterol levels in children undergoing tonsillectomy. SHILAP Revista de lepidopterología. 22(4). 4–12.
9.
Ezzeddini, Rana, et al.. (2012). Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis. International Journal of Pediatric Otorhinolaryngology. 76(4). 471–474. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bohan Dong Breakdown of academic impact, for papers by Marianna Romžová Breakdown of academic impact, for papers by Carolina Marasco Breakdown of academic impact, for papers by Stephen Harper Breakdown of academic impact, for papers by Joseph F. Boland Breakdown of academic impact, for papers by Leticia Soriano‐Baguet Breakdown of academic impact, for papers by Anne Song Breakdown of academic impact, for papers by Yifan Sun Breakdown of academic impact, for papers by Jiaoyu Ai Breakdown of academic impact, for papers by George Sandusky
Rankless by CCL
2026